phase readout
saveNCT07362017: Open Label Study to Investigate the Safety and Efficacy of Ponesimod in Moderate-to-Severe Chronic Plaque Psoriasis
NOT_YET_RECRUITINGupdated 1mo ago
community read0 votes
Sponsor: Vanda Pharmaceuticals. Phase: PHASE3. Conditions: Moderate-to-severe Chronic Plaque Psoriasis
view source ↗
comments(0)
5-min edit window · permanent after that